January 10th, 2011
World’s First Drug Eluting Bioresorbable Stent Gains CE Mark Approval
Larry Husten, PHD
Abbott announced today that it had received CE Mark approval for Absorb, its bioresorbable vascular scaffold (BVS) device. The device props a narrowed coronary artery open but then dissolves within 2 years, leaving the patient without a permanent implant. One hope for the device is that it will allow stent patients to safely discontinue dual […]
NEJM Journal Watch — Recent Cardiology Articles- Which Patients with Cardiogenic Shock Are at Risk for Early Death?
- Cardiac Magnetic Resonance Imaging for Risk Stratification in Nonischemic Cardiomyopathy
- Evidence Mounts for Triple Single-Pill Combination Therapy for Hypertension
- Atherosclerosis Burden and Progression on Imaging and Associated Mortality in Asymptomatic Patients
- Native Hawaiian and Pacific Islander U.S. Adult Cardiovascular Mortality